The ASCENT (Adherence Support Coalition to End TB) project (July 2019 – Dec 2022) builds on existing evidence, innovations in adherence technology and growing global momentum to implement integrated DAT interventions in five key countries (Ethiopia, the Philippines, South Africa, Tanzania, and Ukraine) for all types of TB (DS-TB, DR-TB, LTBI).
Comprised of four key outputs, the ASCENT project will operationalize a DAT intervention in diverse geographic, cultural, and infrastructural settings (Output 1), generate evidence via a shared evaluation framework for optimal use and scale (Output 2), establish a global market for optimized products, price and supply chain models of DAT (Output 3), and engage with key global and in-country stakeholders to prepare for scale-up of the DAT intervention (Output 4).
With its strong consortium of partners (KNCV Tuberculosis Foundation, The Aurum Institute, London School of Hygiene & Tropical Medicine and PATH) and partnership with the governments of the implementing countries, the ASCENT project will contribute to the adoption and uptake of digital adherence technologies. The ASCENT project is made possible thanks to Unitaid’s funding and support.
Countries: Ethiopia, Tanzania, the Philippines, Ukraine and South Africa